MERCHEFORD HOUSE — All Prescriptions & Medications — Page 2
Practice Code: D81064 | MARCH, PE15 9BY
Showing results 51-100 of 571
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Carbocisteine | 865 | 93.5K | £3.3K | +62.0% ▲ |
| Montelukast | 838 | 27.3K | £1.3K | +22.4% ▲ |
| Diazepam | 832 | 25.7K | £581 | +67.0% ▲ |
| Doxazosin mesilate | 818 | 40.5K | £2.4K | -23.4% ▼ |
| Linagliptin | 806 | 18.7K | £21.2K | +96.8% ▲ |
| 762 | 358.1K | £3.0K | -22.6% ▼ | |
| Tramadol hydrochloride | 757 | 91.1K | £2.5K | +5.6% ▲ |
| Empagliflozin | 750 | 29.0K | £36.1K | +19.8% ▲ |
| Atenolol | 742 | 29.3K | £649 | +23.1% ▲ |
| Rosuvastatin calcium | 735 | 26.3K | £2.6K | -18.1% ▼ |
| Pravastatin sodium | 735 | 27.7K | £1.2K | +126.3% ▲ |
| 734 | 120.1K | £3.9K | +54.7% ▲ | |
| Senna | 725 | 24.6K | £591 | +20.5% ▲ |
| Lercanidipine hydrochloride | 718 | 24.6K | £2.5K | +16.2% ▲ |
| Famotidine | 712 | 17.0K | £9.0K | +45.9% ▲ |
| Apixaban | 709 | 37.6K | £3.2K | -46.5% ▼ |
| Nitrofurantoin | 705 | 9,185 | £5.1K | +47.7% ▲ |
| Gliclazide | 693 | 52.6K | £1.5K | -18.6% ▼ |
| Duloxetine hydrochloride | 676 | 18.5K | £1.4K | +6.4% ▲ |
| Finasteride | 672 | 21.6K | £779 | +2.6% ▲ |
| Budesonide | 646 | 1,671 | £25.3K | +19.2% ▲ |
| Morphine sulfate | 645 | 89.4K | £3.8K | -1.6% vs avg |
| Diltiazem hydrochloride | 631 | 22.3K | £3.6K | +105.5% ▲ |
| Insulin aspart | 628 | 3,560 | £22.8K | +64.9% ▲ |
| Venlafaxine | 571 | 24.6K | £15.4K | -32.4% ▼ |
| Hydrocortisone | 553 | 15.4K | £3.4K | +23.3% ▲ |
| Ferrous fumarate | 547 | 27.6K | £1.2K | -24.5% ▼ |
| Fluticasone propionate (Inhalation) | 545 | 807 | £18.2K | +40.8% ▲ |
| Quetiapine | 531 | 15.1K | £6.2K | -14.7% ▼ |
| Desogestrel | 526 | 52.2K | £2.3K | +32.7% ▲ |
| Methotrexate | 513 | 11.9K | £6.4K | +57.6% ▲ |
| Flucloxacillin sodium | 511 | 20.2K | £1.1K | +13.6% ▲ |
| Tirzepatide | 510 | 519 | £49.6K | +162.6% ▲ |
| Cetirizine hydrochloride | 509 | 35.5K | £1.7K | +1.9% vs avg |
| 504 | 598 | £26.6K | +62.3% ▲ | |
| Pantoprazole | 480 | 16.8K | £772 | +74.6% ▲ |
| Alginic acid compound preparations | 474 | 221.5K | £4.0K | -19.1% ▼ |
| Other emollient preparations | 471 | 235.5K | £3.1K | -21.6% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 462 | 53.3K | £4.0K | +205.6% ▲ |
| Digoxin | 454 | 12.1K | £898 | +20.0% ▲ |
| Lamotrigine | 454 | 29.1K | £7.4K | -23.1% ▼ |
| Solifenacin | 454 | 13.9K | £528 | -4.9% ▼ |
| Hydroxocobalamin | 452 | 498 | £1.1K | -6.1% ▼ |
| Mebeverine hydrochloride | 436 | 30.1K | £2.0K | +40.4% ▲ |
| 436 | 7,972 | £3.6K | -34.4% ▼ | |
| Thiamine hydrochloride | 432 | 21.2K | £567 | -18.1% ▼ |
| Melatonin | 429 | 20.7K | £11.2K | +29.0% ▲ |
| Diclofenac diethyl | 420 | 49.7K | £4.4K | +18.3% ▲ |
| Glimepiride | 410 | 20.1K | £596 | +344.3% ▲ |
| Ferrous sulfate | 398 | 35.3K | £1.2K | -22.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.